PATENT CLAIM ANALYSIS

Application Number: 15864496
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["424", "277100"]

Abstract:
Dendritic cells containing tumor lysate loaded particles are prepared. The dendritic cells present tumor antigens to elicit the Major Histocompatibility Complex class I pathway and can be used as a vaccine to treat cancer, including ocular melanoma.

Claim (Index 17):
The method of  claim 16 , the tumor lysate is a lysate of a cancer selected from the group consisting of breast cancer, small cell lung cancer, non-small cell lung cancer, glioma, medulloblastoma, neuroblastoma, Wilms tumors, rhabdomyosarcoma, osteosarcoma, liver cancer, pancreatic cancer, melanoma, prostate cancer and ocular melanoma.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 86.0
- Lexical Diversity: 1.11111
- Patent Class: 424.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14019025', '15656067', '15123479', '13665145', '14248908']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7668602130256548
- 35 USC 102 Novelty (BERT): 0.5663909828313209
- Combined Prediction Score: 0.7468132900062214
- Mean Citation Score: 360.82611000000014
- Max Citation Score: 450.60153
- Similarity Product: 360.678447255342

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test